News
Cytovance Biologics LLC Awarded Biopharmaceutical Development and Manufacturing Contract by Selexys Pharmaceutical Corporation - 04/27/10
Cytovance Biologics LLC Awarded Biopharmaceutical Development and Manufacturing Contract by Selexys Pharmaceutical Corporation [More]
DASGIP Spotlight: Fed Batch Process Scale Up from 0.6 to 100L - 03/18/10
Life Technologies PD-Direct® partnered with Cytovance Biologics to demonstrate rapid process transfer and scale up [More]
Cytovance continues with facility expansion to meet customer demand
[More]
Cytovance Logo - 01/04/10
Cytovance® Biologics announces the hiring of Dr. Jeffrey Su as Vice President of Bioanalytical Development - 08/31/09
Cytovance® Biologics Announces the hiring of Dr. Jeffrey Su as Vice President of Bioanalytical Development to oversee a new state of the art lab as part of its current expansion [More]
Cytovance Newsletter July 2009 - 07/14/09
We are delighted to share with you... [More]
Cytovance® Biologics Announces the Company is Expanding - 05/11/09
Cytovance Biologics® announced today that it is currently in the very late planning stages of expanding... [More]
Oklahoma Becoming Biotech Industry's Hotspot-Featured Video - 03/20/09
Oklahoma is quickly becoming known as a state which business interest stretch beyond energy. In recent years, the state's biotech sector has seen tremendous growth... [More]
Selexys Pharmaceutical Corporation and Cytovance® Biologics Sign Deal for the Process Development and cGMP Manufacture of Selexys Pharmaceutical Corporation’s product HPL1 Monoclonal Antibody (Mab). - 01/26/09
Selexys Pharmaceutical Corporation and Cytovance® Biologics Sign Deal... [More]
EDGE Endowment - 11/19/08
Cytovance Biologics® and Hyalose partner...
Invitrogen and Cytovance® Biologics Collaborate to Develop New Bioreactor Manufacturing Process of Invitrogen’s New CD OptiCHO™ Media Platform - 09/02/08
Cytovance® Biologics LLC announced the completion of a collaboration with Invitrogen’s PD-Direct® Bioprocess Services. [More]
Cytovance® Biologics Announces the Company is Providing Antibody cGMP Manufacturing for ImmunoGen, Inc. - 05/30/08
Cytovance Biologics announced today that ImmunoGen, Inc, has been added... [More]
Cytovance® Biologics Announces New CEO - 03/25/08
Atlanta Biotech Executive to take Helm of
Regional Biopharmaceutical Manufacturing Company... [More]
Bone Biologics Selects Cytovance® Biologics for cGMP Manufacturing of its Breakthrough Bone and Cartilage Regeneration Therapy - 02/13/07
Cytovance® Biologics LLC , a biopharmaceutical contract manufacturing company specializing inthe production of therapeutic proteins and antibodies from... [More]
Biotechnology and Pharmaceutical Industry Veteran to Oversee Manufacturing Operations at Cytovance Biologics - 01/31/06
Cytovance Biologics® today named Steven D. Perry vice president of manufacturing operations. Perry will oversee the clinical... [More]
Cytovance Biologics Selects Sartorius BBI Systems Bioreactors for its Oklahoma City Biopharmaceutical Manufacturing Facility - 11/22/05
Completion of cGMP Facility Validation Anticipated in the Summer of 2006... [More]
Cytovance Biologics Launches Process Development Services for Biopharmaceutical Drug Developers - 01/06/05
Cytovance Biologics Inc., today announced the immediate availability of a comprehensive portfolio of process development services... [More]
Cytovance Biologics completes landmark $16.8 million financing - 07/08/04
Groundbreaking Scheduled Friday, July 9 th at 10:30am... [More]
Financing approved for biologic drug plant - 07/17/03
A financing plan to build a $12 million bio-pharmaceuticals plant for a start-up company won unanimous approval Wednesday from City Urban Renewal Commissioners, who hailed it as... [More]
New biotech company sports familiar faces - 07/17/03
Cytovance Biologics Inc. is a new name on the biotechnology scene, but it is stepping in to solve an old problem... [More]
Biotech firm picks Oklahoma City - 07/01/03
A unique Tax Increment Financing (TIF) package that would provide more than $7 million to construct a $12 million dollar office and production facility here was enough... [More]